Published in Physician Law Weekly, August 18th, 2004
Scientists at Ciphergen's Diagnostics Division discovered over 40 biomarkers that were either increased or decreased in Alzheimer Disease and considered statistically meaningful. These biomarkers encompass many different aspects of AD neuropathology, which make them potentially useful for further research into disease mechanism....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly